Literature DB >> 32253860

Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.

Serkan Türkuçar1, Kaan Yıldız2, Ceyhun Acarı1, Hatice Adıgüzel Dundar1, Mustafa Kır2, Erbil Ünsal1.   

Abstract

Kawasaki disease (KD) is the most common cause of childhood coronary artery disease. The incidence of coronary artery lesions (CALs) has declined with the routine use of intravenous immunoglobulin (IVIG) treatment, but there is still considerable risk for resistance to IVIG treatment and development of CALs. The present study was aimed to determine the risk factors in Turkish children with IVIG resistant KD and coronary artery involvement. Clinical, laboratory and echocardiographic data were retrospectively analyzed in 94 Kawasaki patients. IVIG resistant and responsive groups were compared. The IVIG resistant group had a higher rate of CALs compared to the IVIG responsive group (p < 0.05). Duration of fever ≥ 9.5 days, C-reactive protein (CRP) ≥ 88 mg/L and Neutrophil/lymphocyte ratio (NLR) ≥1.69 were the best cutoff values for predicting IVIG resistance before treatment. The criteria for at least two of these three predictors were considered to be statistically significant risk factors for detecting IVIG resistance in KD before treatment (76.47% sensitivity, 71.05% specificity and 95% CI were 50.1-93.19% and 59.51-80.89%, respectively). Based on the clinical and laboratory features, we established a new risk-scoring system for predicting IVIG resistance in a cohort of Turkish children with KD. This may be useful for choosing optimal treatment for KD to prevent coronary artery involvement.

Entities:  

Keywords:  IVIG resistance; Kawasaki disease; risk score

Year:  2020        PMID: 32253860     DOI: 10.24953/turkjped.2020.01.001

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  5 in total

1.  Differentially expressed genes, lncRNAs, and competing endogenous RNAs in Kawasaki disease.

Authors:  Changsheng Guo; Yuanqing Hua; Zuanhao Qian
Journal:  PeerJ       Date:  2021-05-12       Impact factor: 2.984

Review 2.  Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

Authors:  Alessandra Marchesi; Donato Rigante; Rolando Cimaz; Angelo Ravelli; Isabella Tarissi de Jacobis; Alessandro Rimini; Fabio Cardinale; Marco Cattalini; Andrea De Zorzi; Rosa Maria Dellepiane; Patrizia Salice; Aurelio Secinaro; Andrea Taddio; Paolo Palma; Maya El Hachem; Elisabetta Cortis; Maria Cristina Maggio; Giovanni Corsello; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638

3.  Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.

Authors:  Xiaolan Zheng; Jinhui Li; Peng Yue; Lei Liu; Jiawen Li; Kaiyu Zhou; Yimin Hua; Yifei Li
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

Review 4.  Correct identification of incomplete Kawasaki disease.

Authors:  Tianhua Li; Jie Feng; Na Li; Tingting Liu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis.

Authors:  Chang Liu; Jiacheng Wu
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.